SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares fell despite beating revenue and earnings expectations as investors reacted to a pre-scheduled, multi-million share divestment plan by Chairman Larry Ellison and concerns regarding high AI infrastructure capital expenditures. While many traders view the sell-off as an opportunity to buy, others express frustration over the company's debt levels and the perceived market manipulation suppressing the stock price.

XPeng, Inc. is a global Physical AI company, dedicated to bringing artificial intelligence into the physical world to reshape future mobility and smart living. The firm developed a full-stack Physical AI architecture spanning Turing AI chips, world foundation models, and highly integrated software and hardware applications. The product portfolios of smart EVs, robotaxis, and humanoid robots, advancing the deployment of Physical AI at scale. It manufacturing, sales, and services, drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is trending amid a decline in its share price as investors weigh mixed delivery results against continued uncertainty regarding the impact of its strategic focus on humanoid robotics and global expansion. While some traders view the stock as undervalued given its robotics-related financing and technology partnerships, others are concerned by ongoing price wars in the Chinese EV market and broader bearish sentiment toward China-linked assets.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing significant volatility driven by speculation regarding short squeezes, retail sentiment, and reactions to mixed news, including expansion into Australia and scrutiny over payment dispute rates. While some investors remain bullish on the long-term potential of its telehealth platform and peptide expansion, others are concerned by regulatory pressure and the stock's recent performance.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trading lower following a downgrade from UBS, which cited concerns regarding a prolonged construction timeline and a lack of firm customer commitments. While some market participants remain focused on the long-term potential of the small modular reactor sector, others have expressed frustration over the company's lack of commercial contracts and the potential for further share dilution.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB is experiencing elevated discussion driven by its recent integration of AI-powered trading agents and ongoing speculation regarding a potential spot ETF. Traders are debating these developments alongside broader crypto market volatility and the impact of the Clarity Act on future asset tokenization.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a sharp decline in share price as traders react to the company's recent Phase 3 clinical data for its lead drug sonelokimab and concerns regarding potential share dilution. While some investors remain optimistic about the drug's long-term commercial potential for hidradenitis suppurativa, others are expressing frustration with management's communication strategy and the lack of a definitive acquisition deal.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo shares are trending primarily due to the launch of a new $1 billion at-the-market (ATM) share-sale program, which has intensified investor concerns regarding equity dilution. While some traders express frustration over the company's capital-raising strategy and ongoing insider selling, others remain bullish on the long-term outlook for nuclear energy in supporting AI-driven data center demand.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending following reports of a potential FTC antitrust lawsuit against Amazon over advertising pricing, which investors view as a positive catalyst for the company’s transparent, open-internet business model. Despite this optimism, community sentiment remains deeply polarized, with many traders expressing frustration over recent workforce reductions and ongoing technical weakness as the stock prepares for its S&P 500 index removal.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as investors debate the timing of upcoming military contract awards and evaluate the company's competitive position within the U.S. drone procurement landscape. While some participants express frustration over a perceived lack of official announcements and recent insider share activity, others remain bullish on the sector's long-term growth prospects fueled by government defense initiatives.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Shares are trending lower as investors react to increased volatility and market uncertainty surrounding the timing of the Phase 3 REGAL trial's endpoint. Sentiment is divided between long-term investors maintaining conviction in the clinical trial's potential and traders expressing frustration over the company's communication silence and the influence of unverified third-party models.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
